References
- Ellis C, Luger T. International Consensus Conference on Atopic Dermatitis II (ICCAD II): Clinical update and current treatment strategies. Br J Dermatol. 2003 143(Suppl 63): 3–10.
- Williams HC. Epidemiology of atopic dermatitis. In: Harper J, Orange A, Prose N, editors. Textbook of Pediatric Dermatology. London: Blackwell Science, 2002; p. 161–168.
- Leung DY, Hanifin JM, Charlesworth EN et al. Disease management of atopic dermatitis: a practice parameter. Ann Allergy Asthma Immunol. 1997; 79(3): 197–211.
- Jordaan HF, Visser WI. The diagnosis and management of atopic dermatitis. S Afr Fam Pract. 2009; 51(5): 368–374.
- Lever R. Microbiology of atopic dermatitis. In: Harper J, Orange A, Prose N, editors. Textbook of Pediatric Dermatology. London: Blackwell Science, 2002; p. 194–198.
- Sterling JC, Kurtz JB. Viral infections. In: Champion RH, Burton JL, Burns DA, Breathnach SM, editors. Textbook of Dermatology.6th ed. London: Blackwell Science, 1998; p. 995–1095.
- Holden CA, Parish WE. Atopic dermatitis. In: Champion RH, Burton JL, Burns DA, Breathnach SM, editors. Textbook of Dermatology. London: Blackwell Science, 1998; p. 681–708.
- Potter PC. A therapeutic approach to atopic eczema. S Afr Fam Pract. 2010; 52(4): 277–282.
- Bingham EA. Guidelines to management of atopic dermatitis. In: Harper J, Orange A, Prose N, editors. Textbook of Pediatric Dermatology. London: Blackwell Science, 2002; p. 215–230.
- Manjra AI, Du Plessis P, Weiss R et al. Childhood atopic eczema consensus document. S Afr Med J. 2005; 95(6): 435–440.
- Novartis South Africa (Pty) Ltd. Proposed package insert for Elidel 1 % cream. Kempton Park: 2009 Jun 12.
- Astellas Pharma (Pty) Ltd. Protopic 0.03% ointment. Protopic 0.1 % ointment. Bedfordview: 2009 Apr 17.